HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
Autor: | Fokom Domgue J; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaoundé, Cameroon.; Department of Gynecology and Obstetrics, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaoundé, Cameroon.; Centre Inter-Etats d'Enseignement Supérieur en Santé Publique d'Afrique Centrale, Brazzaville, Republic of Congo., Dille I; Division of Noncommunicable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo., Kapambwe S; Division of Noncommunicable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo., Yu R; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gnangnon F; Division of Surgical Oncology, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin., Chinula L; University of North Carolina Project-Malawi, Lilongwe, Malawi.; Division of Global Women's Health, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Murenzi G; Einstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.; Department of Pathology, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mbatani N; Gynecologic Oncology Unit, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Pande M; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sidibe F; Medical Oncology Unit, CHU du Point G, Faculty of Medicine and Dentistry, University of Bamako, Bamako, Mali., Kamgno J; Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaoundé, Cameroon., Traore B; Division of Surgical Oncology, Faculty of Health Sciences and Technics, University Gamal Abdel Nasser of Conakry, Conakry, Guinea., Fazazi HE; Department of Gynecology and Obstetrics, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco., Diop M; Institut du Cancer Joliot Curie, CHU Aristide Le Dantec, Dakar, Senegal., Tebeu PM; Department of Gynecology and Obstetrics, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaoundé, Cameroon.; Centre Inter-Etats d'Enseignement Supérieur en Santé Publique d'Afrique Centrale, Brazzaville, Republic of Congo., Diomande MI; Department of Pathology, University Teaching Hospital of Cocody, Abidjan, Côte d'Ivoire., Lecuru F; Department of Gynecologic and Breast Surgical Oncology, Institut Curie, Paris, France., Adewole I; Department of Obstetrics and Gynecology, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria., Plante M; Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Laval University, Québec City, QC, Canada., Basu P; Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France., Dangou JM; Division of Noncommunicable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo., Shete S; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in public health [Front Public Health] 2024 Jan 17; Vol. 12, pp. 1343064. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024). |
DOI: | 10.3389/fpubh.2024.1343064 |
Abstrakt: | Introduction: Although the burden of cervical cancer in Africa is highest, HPV vaccination coverage remains alarmingly low in this region. Providers' knowledge and recommendation are key drivers of HPV vaccination uptake. Yet, evidence about providers' knowledge and recommendation practices about the HPV vaccine against a backdrop of emerging vaccine hesitancy fueled by the COVID-19 pandemic is lacking in Africa. Methods: A cross-sectional study was conducted in 2021-2022 among healthcare providers involved in cervical cancer prevention activities in Africa. They were invited to report prior training, the availability of the HPV vaccine in their practice, whether they recommended the HPV vaccine, and, if not, the reasons for not recommending it. Their knowledge about the HPV vaccine was assessed through self-reporting (perceived knowledge) and with three pre-tested knowledge questions (measured knowledge). Results: Of the 153 providers from 23 African countries who responded to the survey (mean age: 38.5 years, SD: 10.1), 75 (54.0%) were female and 97 (63.4%) were based In countries with national HPV immunization programs. Overall, 57 (43.8%) reported having received prior training on HPV vaccine education/counseling, and 40 (37.4%) indicated that the HPV vaccine was available at the facility where they work. Most respondents (109, 83.2%) reported recommending the HPV vaccine in their practice. Vaccine unavailability (57.1%), lack of effective communication tools and informational material (28.6%), and need for adequate training (28.6%) were the most commonly reported reasons for not recommending the HPV vaccine. While 63 providers (52.9%) reported that their knowledge about HPV vaccination was adequate for their practice, only 9.9% responded correctly to the 3 knowledge questions. Conclusion: To increase HPV vaccination coverage and counter misinformation about this vaccine in Africa, adequate training of providers and culturally appropriate educational materials are needed to improve their knowledge of the HPV vaccine and to facilitate effective communication with their patients and the community. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Fokom Domgue, Dille, Kapambwe, Yu, Gnangnon, Chinula, Murenzi, Mbatani, Pande, Sidibe, Kamgno, Traore, El Fazazi, Diop, Tebeu, Diomande, Lecuru, Adewole, Plante, Basu, Dangou and Shete.) |
Databáze: | MEDLINE |
Externí odkaz: |